Publications

5674 Results

Addressing skyrocketing cancer drug prices comes with tradeoffs: pick your poison. [Opinion]

Authors
S Ramsey;GH Lyman;R Bangs
Journal / Conference
JAMA Oncology, Apr 1;2(4):425-426; 2016 Feb 11 [Epub ahead of print]
Year
2016
Research Committee(s)
Cancer Care Delivery
PMID
PMID26868102
PMC
PMC n/a [opinion article]

Next steps for adolescent and young adult oncology workshop: An update on progress and recommendations for the future [Review]

Authors
AW Smith;NL Seibel;DR Lewis;KH Albritton;DF Blair;CD Blanke;A Bleyer;DR Freyer;AM Geiger;B Hayes-Lattin;JV Tricoli;LI Wagner;BJ Zebrack
Journal / Conference
Cancer Apr 1;122(7):988-999
Year
2016
Research Committee(s)
Cancer Care Delivery
PMID
PMID26849003
PMC
PMC n/a - review article

Comorbidities and risk of chemotherapy induced peripheral neuropathy among participants in SWOG clinical trials

Authors
DL Hershman;C Till;JD Wright;D Awad;S Ramsey;W Barlow;L Minasian;J Unger
Journal / Conference
Journal of Clinical Oncology 34, 2016 (suppl; abstr 10001); American Society of Clinical Oncology Annual Meeting (June 3-7, 2016, Chicago, IL), oral presentation
Year
2016
Research Committee(s)
Breast, Genitourinary, Gynecologic, Head and Neck, and Lung
Study Number(s)
S0003, S0007, S0009, S0012, S0022, S0023, S0027, S0028, S0029, S0032, S0102, S0219, S0221, S0329, S0421, S0536, S0819, S9712, S9900, S9902, S9912, S9914, S9916

Azacitidine with or without entinostat for the treatment of therapy-related myeloid neoplasm: further results of the E1905 North American Leukemia Intergroup study

Authors
T Prebet;Z Sun;R Ketterling;A Zeidan;P Greenberg;J Herman;M Juckett;MR Smith;L Malick;E Paietta;M Czader;M Figueroa;J Gabrilove;H Erba;M Tallman;M Litzow;S Gore
Journal / Conference
British Journal of Haematology, Feb;172(3):384-391
Year
2016
Research Committee(s)
Leukemia
PMID
PMID26577691
PMC
PMC4794257
Study Number(s)
E1905

Determinants of early mortality among 37,568 patients with colon cancer who participated in 25 clinical trials from the Adjuvant Colon Cancer Endpoints Database

Authors
WY Cheung;LA Renfro;D Kerr;A de Gramont;LB Saltz;A Grothey;SR Alberts;T Andre;KA Guthrie;R LaBianca;G Francini;J-F Seitz;C O'Callaghan;C Twelves;E Van Cutsem;DG Haller;G Yothers;DJ Sargent
Journal / Conference
Journal of Clinical Oncology, Apr 10;34(11):1182-1189
Year
2016
Research Committee(s)
Gastrointestinal
PMID
PMID26858337
PMC
PMC4933130
Study Number(s)
SWOG-9415 (INT-0153) (CALGB-9498) (ECOG-S9415) (NCCTG-S9415)

Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance)

Authors
AM Lee;Q Shi Qian;SR Alberts;DJ Sargent;FA Sinicrope;JL Berenberg;A Grothey;B Polite;E Chan;S Gill;MS Kahlenberg;SG Nair;AF Shields;RM Goldberg;RB Diasio
Journal / Conference
Pharmacogenetics and Genomics, Mar;26(3):133-137
Year
2016
Research Committee(s)
Gastrointestinal
PMID
PMID26658227
PMC
PMC4738010
Study Number(s)
CTSU/N0147

A phase III randomized trial comparing FDA approved standard of care adjuvant therapy to one year of pembrolizumab in patients with high risk resected melanoma SWOG 1404

Authors
K Grossmann;V Sondak;M Othus;A Tarhini;S Patel;J Kirkwood;A Ribas;J Moon
Journal / Conference
American Association for Cancer Research Annual Meeting (2016, April 16-20, New Orleans, LA), poster session, abst #CT125
Year
2016
Research Committee(s)
Melanoma
Study Number(s)
S1404

Bone biomarkers and overall survival (OS) in men with castration resistant prostate cancer (CRPC) and skeletal metastases: updated results from SWOG 0421, a phase III trial of docetaxel +/- atrasentan

Authors
PN Lara;M Plets;C Tangen;E Gertz;N Vogelzang;D Quinn;I Thompson;M van Loan
Journal / Conference
Annals of Oncology vol. 27, 2016 Supp 6, abst. 754P; European Society for Medical Oncology (October 7-11, 2016, Copenhagen, Denmark), poster
Year
2016
Research Committee(s)
Genitourinary
Study Number(s)
S0421

A meta-analysis of individual participant data reveals an association between circulating levels of IGF-I and prostate risk

Authors
R Travis;P Appleby;RM Martin;JMP Holly;D Albanes;A Black;HB Bueno-de-Mesquita;JM Chan;C Chen;MD Chirlaque;MB Cook;M Deschasaux;JL Donovan;L Ferrucci;P Galan;G Giles;E Giovannucci;M Gunter;LA Habel;FC Hamdy;K Helzlsouer;S Hercberg;RN Hoover;J Janssen;R Kaaks;T Kubo;T Kubo;L Le Marchand;EJ Metter;K Mikami;JK Morris;D Neal;M Neuhouser;K Ozasa;D Palli;M Pollak;E Platz;AJ Price;MJ Roobol;C Schaefer;J Schenk;G Severi;M Stampfer;P Stattin;A Tamakoshi;C Tangen;M Touvier;NJ Wald;N Weiss;R Ziegler;TJ Key;NE Allen
Journal / Conference
Cancer Research Apr 15;76(8):2288-2300; 2016 Feb 26 [Epub ahead of print]
Year
2016
Research Committee(s)
Cancer Control, Prevention, Screening, and and Surveillance
PMID
PMID26921328
PMC
PMC4873385
Study Number(s)
SWOG-9217

Blood-Based Biomarkers in Patients (pts) with Metastatic Colorectal Cancer (mCRC) Treated with FOLFOX or FOLFIRI + Bevacizumab (Bev), Cetuximab (Cetux), or Bev + Cetux: Results from CALGB 80405 (Alliance)

Authors
AB Nixon;AB Sibley;AJ Hatch;Y Liu;C Jiang;F Mulkey;MD Starr;JC Brady;D Niedzwiecki;F Innocenti;A Venook;H Hochster;H Lenz;B O'Neil;K Owzar;H Hurwitz
Journal / Conference
Journal of Clinical Oncology 34, 2016 (suppl; abstr 3597); American Society of Clinical Oncology Annual Meeting (June 3-7, 2016, Chicago, IL), poster session
Year
2016
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80405